Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Anti Acne Dermal Patch Market

ID: MRFR/HC/49710-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

South Korea Anti-Acne Dermal Patch Market Research Report: Size, Share, Trend Analysis By Acne Type (Inflammatory Acne, Non-inflammatory Acne), By Patch Type (Medicated, Non-Medicated, Micro-Needle), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, E-Commerce Platform) and By Ingredient Type (Chemical Based, Herbal Based) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Anti Acne Dermal Patch Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Life Sciences, BY Acne Type (USD Million)
  49.     4.1.1 Inflammatory Acne
  50.     4.1.2 Non-inflammatory Acne
  51.   4.2 Life Sciences, BY Patch Type (USD Million)
  52.     4.2.1 Medicated
  53.     4.2.2 Non-Medicated
  54.     4.2.3 Micro-Needle
  55.   4.3 Life Sciences, BY Distribution Channel (USD Million)
  56.     4.3.1 Retail Stores
  57.     4.3.2 Pharmacies & Drug Stores
  58.     4.3.3 E-Commerce Platform
  59.   4.4 Life Sciences, BY Ingredient Type (USD Million)
  60.     4.4.1 Chemical Based
  61.     4.4.2 Herbal Based
  62. 5 SECTION V: COMPETITIVE ANALYSIS
  63.   5.1 Competitive Landscape
  64.     5.1.1 Overview
  65.     5.1.2 Competitive Analysis
  66.     5.1.3 Market share Analysis
  67.     5.1.4 Major Growth Strategy in the Life Sciences
  68.     5.1.5 Competitive Benchmarking
  69.     5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  70.     5.1.7 Key developments and growth strategies
  71.       5.1.7.1 New Product Launch/Service Deployment
  72.       5.1.7.2 Merger & Acquisitions
  73.       5.1.7.3 Joint Ventures
  74.     5.1.8 Major Players Financial Matrix
  75.       5.1.8.1 Sales and Operating Income
  76.       5.1.8.2 Major Players R&D Expenditure. 2023
  77.   5.2 Company Profiles
  78.     5.2.1 Nippon Shikizai Inc (JP)
  79.       5.2.1.1 Financial Overview
  80.       5.2.1.2 Products Offered
  81.       5.2.1.3 Key Developments
  82.       5.2.1.4 SWOT Analysis
  83.       5.2.1.5 Key Strategies
  84.     5.2.2 Hero Cosmetics (US)
  85.       5.2.2.1 Financial Overview
  86.       5.2.2.2 Products Offered
  87.       5.2.2.3 Key Developments
  88.       5.2.2.4 SWOT Analysis
  89.       5.2.2.5 Key Strategies
  90.     5.2.3 COSRX (KR)
  91.       5.2.3.1 Financial Overview
  92.       5.2.3.2 Products Offered
  93.       5.2.3.3 Key Developments
  94.       5.2.3.4 SWOT Analysis
  95.       5.2.3.5 Key Strategies
  96.     5.2.4 Mediheal (KR)
  97.       5.2.4.1 Financial Overview
  98.       5.2.4.2 Products Offered
  99.       5.2.4.3 Key Developments
  100.       5.2.4.4 SWOT Analysis
  101.       5.2.4.5 Key Strategies
  102.     5.2.5 Neutrogena (US)
  103.       5.2.5.1 Financial Overview
  104.       5.2.5.2 Products Offered
  105.       5.2.5.3 Key Developments
  106.       5.2.5.4 SWOT Analysis
  107.       5.2.5.5 Key Strategies
  108.     5.2.6 The Ordinary (CA)
  109.       5.2.6.1 Financial Overview
  110.       5.2.6.2 Products Offered
  111.       5.2.6.3 Key Developments
  112.       5.2.6.4 SWOT Analysis
  113.       5.2.6.5 Key Strategies
  114.     5.2.7 Peach Slices (US)
  115.       5.2.7.1 Financial Overview
  116.       5.2.7.2 Products Offered
  117.       5.2.7.3 Key Developments
  118.       5.2.7.4 SWOT Analysis
  119.       5.2.7.5 Key Strategies
  120.     5.2.8 Bioré (JP)
  121.       5.2.8.1 Financial Overview
  122.       5.2.8.2 Products Offered
  123.       5.2.8.3 Key Developments
  124.       5.2.8.4 SWOT Analysis
  125.       5.2.8.5 Key Strategies
  126.   5.3 Appendix
  127.     5.3.1 References
  128.     5.3.2 Related Reports
  129. 6 LIST OF FIGURES
  130.   6.1 MARKET SYNOPSIS
  131.   6.2 SOUTH KOREA MARKET ANALYSIS BY ACNE TYPE
  132.   6.3 SOUTH KOREA MARKET ANALYSIS BY PATCH TYPE
  133.   6.4 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  134.   6.5 SOUTH KOREA MARKET ANALYSIS BY INGREDIENT TYPE
  135.   6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
  136.   6.7 RESEARCH PROCESS OF MRFR
  137.   6.8 DRO ANALYSIS OF LIFE SCIENCES
  138.   6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
  139.   6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
  140.   6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
  141.   6.12 LIFE SCIENCES, BY ACNE TYPE, 2024 (% SHARE)
  142.   6.13 LIFE SCIENCES, BY ACNE TYPE, 2024 TO 2035 (USD Million)
  143.   6.14 LIFE SCIENCES, BY PATCH TYPE, 2024 (% SHARE)
  144.   6.15 LIFE SCIENCES, BY PATCH TYPE, 2024 TO 2035 (USD Million)
  145.   6.16 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  146.   6.17 LIFE SCIENCES, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  147.   6.18 LIFE SCIENCES, BY INGREDIENT TYPE, 2024 (% SHARE)
  148.   6.19 LIFE SCIENCES, BY INGREDIENT TYPE, 2024 TO 2035 (USD Million)
  149.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  150. 7 LIST OF TABLES
  151.   7.1 LIST OF ASSUMPTIONS
  152.     7.1.1
  153.   7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  154.     7.2.1 BY ACNE TYPE, 2025-2035 (USD Million)
  155.     7.2.2 BY PATCH TYPE, 2025-2035 (USD Million)
  156.     7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
  157.     7.2.4 BY INGREDIENT TYPE, 2025-2035 (USD Million)
  158.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  159.     7.3.1
  160.   7.4 ACQUISITION/PARTNERSHIP
  161.     7.4.1

South Korea Life Sciences Market Segmentation

Life Sciences By Acne Type (USD Million, 2025-2035)

  • Inflammatory Acne
  • Non-inflammatory Acne

Life Sciences By Patch Type (USD Million, 2025-2035)

  • Medicated
  • Non-Medicated
  • Micro-Needle

Life Sciences By Distribution Channel (USD Million, 2025-2035)

  • Retail Stores
  • Pharmacies & Drug Stores
  • E-Commerce Platform

Life Sciences By Ingredient Type (USD Million, 2025-2035)

  • Chemical Based
  • Herbal Based

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions